AxoGen, Inc. (AXGN)

Last Closing Price: 22.22 (2025-10-31)

Shareholders Equity (Quarterly)

Shareholders Equity: The sum of preferred and common equity items.

AxoGen, Inc. (AXGN) had Shareholders Equity of $120.81M for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
$60.08M
$0.71M
$14.09M
$45.99M
$58.17M
$1.91M
$-1.20M
$0.71M
$0.71M
$0.71M
$0.71M
$0.71M
$0.71M
$1.91M
$3.98M
46.49M
49.09M
$0.02
$0.01
Balance Sheet Financials
$114.46M
$82.37M
$101.94M
$216.40M
$28.01M
$65.58M
$67.59M
$95.59M
$120.81M
$114.37M
Shareholders Equity
$120.81M
46.12M
Cash Flow Statement Financials
$-2.23M
$-9.36M
$5.93M
$33.55M
$27.90M
$-5.65M
$13.50M
--
--
Fundamental Metrics & Ratios
4.09
--
--
0.35
0.56
76.55%
3.18%
3.18%
--
1.18%
1.18%
$-4.72M
--
--
--
0.28
0.35
1.95
46.10
0.59%
0.62%
0.33%
0.38%
$2.62
$-0.10
$-0.05